HemaSphere (Jun 2022)
P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB
- S. Le Gouill,
- M. Długosz-Danecka,
- S. Rule,
- P. Luigi Zinzani,
- A. Goy,
- S. D. Smith,
- J. K. Doorduijn,
- C. Panizo,
- B. Shah,
- A. Davies,
- R. Eek,
- E. Jacobsen,
- A. P. Kater,
- T. Robak,
- P. Jain,
- R. Calvo,
- H. Yang,
- M. Wang
Affiliations
- S. Le Gouill
- 1 Institut Curie, Paris, France
- M. Długosz-Danecka
- 2 Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
- S. Rule
- 3 Plymouth University Medical School, Plymouth, United Kingdom
- P. Luigi Zinzani
- 5 IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli,” Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy
- A. Goy
- 6 John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
- S. D. Smith
- 7 University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America
- J. K. Doorduijn
- 8 Erasmus MC Cancer Institute, HOVON Lunenburg Lymphoma Phase I/II Consortium, Rotterdam, Netherlands
- C. Panizo
- 9 Clínica Universidad de Navarra, Pamplona, Spain
- B. Shah
- 10 Moffitt Cancer Center, Tampa, FL, United States of America
- A. Davies
- 11 Cancer Research UK Experimental Cancer Medicines Centre, University of Southampton Faculty of Medicine, Southampton, United Kingdom
- R. Eek
- 12 Border Medical Oncology, Albury, NSW, Australia
- E. Jacobsen
- 13 Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States of America
- A. P. Kater
- 14 Amsterdam University Medical Center, Amsterdam, on behalf of HOVON, Amsterdam, Netherlands
- T. Robak
- 15 Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland
- P. Jain
- 16 MD Anderson Cancer Center, University of Texas, Houston, TX
- R. Calvo
- 17 AstraZeneca, Gaithersburg, MD
- H. Yang
- 18 AstraZeneca, South San Francisco, CA, United States of America
- M. Wang
- 16 MD Anderson Cancer Center, University of Texas, Houston, TX
- DOI
- https://doi.org/10.1097/01.HS9.0000847392.35657.0d
- Journal volume & issue
-
Vol. 6
pp. 1021 – 1022
Abstract
No abstracts available.